KIORA PHARMACEUTICALS INC (KPRX) Stock Income Statement
USA - NASDAQ:KPRX - US49721T5074 - Common Stock
2.31 USD
-0.24 (-9.41%)
2.3281 USD
+0.02 (+0.78%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 16.02M | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 8.89M | 9.50M | 10.68M | 12.31M | 10.20M | |||
| Research and Development | 10.56M | 7.84M | 4.03M | 3.45M | 5.35M | |||
| Selling, General, and Administrative Expenses | 5.55M | 5.54M | 4.66M | 8.28M | 5.32M | |||
| Operating Income | -8.89M | 6.52M | -10.68M | -12.31M | -10.20M | |||
| Interest Income/Expense | 1.17M | 1.23M | 162.90K | -1.39M | -10.00K | |||
| Other Income/Expense | -73.00K | 26.10K | 28.80K | N/A | -30.00K | |||
| Non Recurring Items | N/A | -2.11M | -1.90M | 0.00 | -3.76M | |||
| Income Before Taxes | -9.91M | 5.66M | -12.42M | -13.70M | -13.96M | |||
| Income Tax | N/A | 2.06M | 90.30K | -110.00K | -190.00K | |||
| Net Income | -11.98M | 3.59M | -13.04M | -13.58M | -13.77M | |||
| EBITDA | -8.87M | 6.54M | -10.63M | -12.27M | -10.15M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.87 | 0.87 | -2.69 | -18.60 | -57.37 | |||
| Non GAAP EPS | -2.91 | 1.04 | -28.35 | -232.11 | -601.86 | |||
| Statistics | ||||||||
| Profit Margin | N/A | 22.44% | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | 40.69% | N/A | N/A | N/A | |||
All data in USD